Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Julie R. Stegeman x
  • Refine by Access: Content accessible to me x
Clear All Modify Search

Abstract

Objective—To evaluate response of euthyroid cats to administration of recombinant human thyroid-stimulating hormone (rhTSH).

Animals—7 healthy cats.

Procedure—Each cat received each of 5 doses of rhTSH (0, 0.025, 0.050, 0.100, and 0.200 mg), IV, at 1-week intervals. Serum concentration of total thyroxine (TT4) and free thyroxine (fT4) was measured immediately before each injection (time 0) and 2, 4, 6, and 8 hours after administration of each dose.

Results—Overall TT4 response did not differ significantly among cats when administered doses were ≥ 0.025 mg. Serum TT4 concentrations peaked 6 to 8 hours after administration for all doses ≥ 0.025 mg. For all doses ≥ 0.025 mg, mean ± SEM TT4 concentration at 0, 6, and 8 hours was 33.9 ± 1.7, 101.8 ± 5.9, and 101.5 ± 5.7 nmol/L, respectively. For all doses ≥ 0.025 mg, mean fT4 concentration at 0, 6, and 8 hours was 38.7 ± 2.9, 104.5 ± 7.6, and 100.4 ± 8.0 pmol/L, respectively. At 8 hours, the fT4 response to 0.025 and 0.050 mg was less than the response to 0.100 and 0.200 mg. Adverse reactions after rhTSH administration were not detected.

Conclusions and Clinical Relevance—The TSH stimulation test can be performed in cats by IV administration of 0.025 to 0.200 mg of rhTSH and measurement of serum TT4 concentrations at time of injection and 6 or 8 hours later. Clinical validation of the TSH stimulation test would facilitate development of additional tests of thyroid gland function, such as a TSH assay. (Am J Vet Res 2003;64:149–152)

Full access
in American Journal of Veterinary Research